Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses
Yue Ma, Estrella Frutos-Beltrán, Dongwei Kang, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 7, pp. 4514-4540
Open Access | Times Cited: 132

Showing 51-75 of 132 citing articles:

Opportunities and challenges in new HIV therapeutic discovery: what is the next step?
Shujing Xu, Lin Sun, Xinyong Liu, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 11, pp. 1195-1199
Open Access | Times Cited: 7
Antiviral innovations in largemouth bass aquaculture: Unveiling the potential of arctigenin derivatives against Micropterus Salmoides rhabdovirus
Guanglu Liu, Wenke Dong, Chunjie Wang, et al.
Aquaculture (2024) Vol. 582, pp. 740546-740546
Closed Access | Times Cited: 2
Machine learning and molecular simulation-based protocols to identify novel potential inhibitors for reverse transcriptase against HIV infections
Muhammad Shahab, Guojun Zheng, Yousef A. Bin Jardan, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-14
Closed Access | Times Cited: 2
Classical swine fever virus non-structural protein 4A recruits dihydroorotate dehydrogenase to facilitate viral replication
Bing-qian Zhao, Jing Chen, Jinxia Chen, et al.
Journal of Virology (2024) Vol. 98, Iss. 6
Open Access | Times Cited: 2
Mapping mutational fitness effects across the coxsackievirus B3 proteome reveals distinct profiles of mutation tolerability
Beatriz Álvarez‐Rodríguez, Sebastián Velandia-Álvarez, Christina Toft, et al.
PLoS Biology (2024) Vol. 22, Iss. 7, pp. e3002709-e3002709
Open Access | Times Cited: 2
Daphnetin may protect from SARS-CoV-2 infection by reducing ACE2
Qian-wen Yang, Chang-Ling Yue, Meng Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors
Xujie Zhang, Lin Sun, Megan E. Meuser, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113848-113848
Open Access | Times Cited: 17
The discovery and design of novel HIV-1 capsid modulators and future perspectives
Dang Ding, Shujing Xu, Xujie Zhang, et al.
Expert Opinion on Drug Discovery (2022) Vol. 18, Iss. 1, pp. 5-12
Closed Access | Times Cited: 11
What Have We Learned by Resurrecting the 1918 Influenza Virus?
Brad Gilbertson, Kanta Subbarao
Annual Review of Virology (2023) Vol. 10, Iss. 1, pp. 25-47
Open Access | Times Cited: 6
Current medicinal chemistry strategies in the discovery of novel HIV-1 ribonuclease H inhibitors
Lina Zhang, Fenju Wei, Jiwei Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114760-114760
Closed Access | Times Cited: 10
Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications
Peng Chen, Liang Lou, Bigyan Sharma, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 20, pp. 2955-2973
Closed Access | Times Cited: 5
Synthetic approaches and application of clinically approved small-molecule Anti-HIV drugs: An update
Lu Sun, Peng Nie, Luan Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115847-115847
Closed Access | Times Cited: 5
Approaches for discovery of small-molecular antivirals targeting to influenza A virus PB2 subunit
Wenteng Chen, Jiaan Shao, Zhimin Ying, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 6, pp. 1545-1553
Open Access | Times Cited: 9
Lead Optimization and Avoidance of Metabolic-perturbing Motif Developing Novel Diarylpyrimidines as Potent HIV-1 NNRTIs
Yanying Sun, Zhenzhen Zhou, Da Feng, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 23, pp. 15608-15626
Closed Access | Times Cited: 9
Exploiting Modeling Studies for Evaluating the Potential Antiviral Activities of some Clinically Approved Drugs and Herbal Materials against SARS-CoV-2: Theoretical Studies toward Hindering the Virus and Blocking the Human Cellular Receptor
Eslam M. Abbass, Ali Kh. Khalil, Yousra Abdel–Mottaleb, et al.
Polycyclic aromatic compounds (2023) Vol. 44, Iss. 2, pp. 1209-1220
Closed Access | Times Cited: 5
Structure-based design and optimization lead to the identification of novel dihydrothiopyrano[3,2-d]pyrimidine derivatives as potent HIV-1 inhibitors against drug-resistant variants
Zhao Wang, Heng Zhang, Zhen Gao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 1257-1282
Open Access | Times Cited: 5
Disubstituted pyrimidine-5-carboxamide derivatives as novel HIV-1 NNRTIs: Crystallographic overlay-based molecular design, synthesis, and biological evaluation
Da Feng, Hao Lin, Liyang Jiang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114957-114957
Closed Access | Times Cited: 8
Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulators
Xujie Zhang, Lin Sun, Shujing Xu, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 7, pp. 1272-1295
Open Access | Times Cited: 4
Nutritional and pharmacological potentials of the medicinal mushroom Ganoderma adspersum (Schulz.) Donk
Sana Hamrouni Zahmoul, Rim Ladhar Chaabouni, Ameny Srih, et al.
South African Journal of Botany (2024) Vol. 166, pp. 360-374
Open Access | Times Cited: 1
Discovery of Potent DAG-Lactone Derivatives as HIV Latency Reversing Agents
Takahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 6, pp. 2250-2261
Closed Access | Times Cited: 1
PROTAC Beyond Cancer- Exploring the New Therapeutic Potential o f Proteolysis Targeting Chimeras
Ritesh Bhole, S. Patil, Harshad S. Kapare, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 23, pp. 2050-2073
Closed Access | Times Cited: 1
Synthesis and Antinociceptive Activity of Substituted Derivatives of Potassium 1-Cyano-3-{(3-cyano-4,5,6,7-tetrahydrobenzo-[b]thiophen-2-yl)amino}-5-oxopenta-1,3-dien-2-olates
D. A. Kozlov, D. V. Lipin, I. A. Gorbunova, et al.
Russian Journal of General Chemistry (2024) Vol. 94, Iss. 5, pp. 1024-1030
Closed Access | Times Cited: 1
Orally Bioavailable RORγ/DHODH Dual Host-Targeting Small Molecules with Broad-Spectrum Antiviral Activity
Alexandra Herrmann, Christian Gege, Christina Wangen, et al.
Antiviral Research (2024), pp. 106008-106008
Open Access | Times Cited: 1
Harnessing PROTACs to combat H5N1 influenza: A new frontier in viral destruction
Nobendu Mukerjee, Swastika Maitra, Dattatreya Mukherjee, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 9
Open Access | Times Cited: 1
Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: A review
Muhammad Salman Hameed, Hongxuan Cao, Li Guo, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100217-100217
Open Access | Times Cited: 1

Scroll to top